Higg Index

Sustainable Apparel Coalition Rebrands as Cascale

Retrieved on: 
Monday, February 26, 2024

The Sustainable Apparel Coalition (SAC) enters a new phase of positive impact, rebranding as Cascale, a global nonprofit alliance that empowers collaboration to drive equitable and restorative business practices in the consumer goods industry.

Key Points: 
  • The Sustainable Apparel Coalition (SAC) enters a new phase of positive impact, rebranding as Cascale, a global nonprofit alliance that empowers collaboration to drive equitable and restorative business practices in the consumer goods industry.
  • The “C” in Cascale evokes a new “phase” similar to lunar cycles in nature, as well as moonlight or a mirrored reflection.
  • Cascale works collaboratively to shift the industry from silos to collective action: With the Apparel Alliance (Apparel Impact Institute, Textile Exchange, ZDHC Foundation, and Cascale), Social & Labor Convergence Program, Policy Hub, Fair Wear Foundation, Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH programs, and many others, Cascale continuously develops and supports initiatives that aim to catalyze impact at scale.
  • Cascale remains committed to embracing the diverse perspectives of our members, partners, and external stakeholders to align on meaningful action.”

Taking Stock of Fashion's Progress towards Net Positive: Industry organisations consolidate sustainability guidance and present new data

Retrieved on: 
Thursday, November 30, 2023

The second GFA Monitor has been updated to include the latest guidance and insights from over 25 industry organisations in one cohesive publication.

Key Points: 
  • The second GFA Monitor has been updated to include the latest guidance and insights from over 25 industry organisations in one cohesive publication.
  • For the first time, the report includes new data insights from the Fashion Industry Target Consultation - drawn from over 900 industry participants in 90 countries.
  • GFA welcomes further cooperation with other industry organisations as the annual report evolves and responds to industry and scientific developments.
  • Scott Raskin, CEO, Worldly, Data Partner for The GFA Monitor, says: "To address climate change, the apparel industry needs primary supply chain data at scale.

Taking Stock of Fashion's Progress towards Net Positive: Industry organisations consolidate sustainability guidance and present new data

Retrieved on: 
Thursday, November 30, 2023

The second GFA Monitor has been updated to include the latest guidance and insights from over 25 industry organisations in one cohesive publication.

Key Points: 
  • The second GFA Monitor has been updated to include the latest guidance and insights from over 25 industry organisations in one cohesive publication.
  • For the first time, the report includes new data insights from the Fashion Industry Target Consultation - drawn from over 900 industry participants in 90 countries.
  • GFA welcomes further cooperation with other industry organisations as the annual report evolves and responds to industry and scientific developments.
  • Scott Raskin, CEO, Worldly, Data Partner for The GFA Monitor, says: "To address climate change, the apparel industry needs primary supply chain data at scale.

Worldly Launches Next Generation Facility Environmental Assessment for Consumer Goods Brands and Retailers

Retrieved on: 
Thursday, November 2, 2023

To help businesses address pressing climate issues and meet growing regulatory requirements, the industry-leading environmental assessment now aligns with global carbon frameworks.

Key Points: 
  • To help businesses address pressing climate issues and meet growing regulatory requirements, the industry-leading environmental assessment now aligns with global carbon frameworks.
  • Higg FEM stands as the foremost self-assessment tool for manufacturing supply chains to transparently communicate their environmental impact with brands.
  • Over the years, this tool has played a crucial role in helping tens of thousands of global consumer goods manufacturers understand and communicate their environmental footprint.
  • “We’re excited to continue working with Worldly to help provide manufacturing facilities and global brands the best environmental assessment to address climate change and meet today's emerging regulations."

Sappi Cloquet Dissolving Pulp Facility Completes the Higg FEM Assessment

Retrieved on: 
Tuesday, October 31, 2023

Sappi Limited , a leading producer of dissolving pulp sold under the brand name Verve, continues to reach new milestones by completing the Higg Facility Environmental Management (FEM) verification audit at its Cloquet mill.

Key Points: 
  • Sappi Limited , a leading producer of dissolving pulp sold under the brand name Verve, continues to reach new milestones by completing the Higg Facility Environmental Management (FEM) verification audit at its Cloquet mill.
  • Based in Northern Minnesota, USA, the mill is one of the leading dissolving pulp facilities to complete this external verification process.
  • “As a global leader in dissolving pulp manufacturing, we are excited that our commitment to the sustainable manufacture of our Sappi Verve product is confirmed by the SAC Higg FEM results,” said Tom Radovich, Managing Director of Sappi North America’s Cloquet mill.
  • To learn more about Sappi’s dissolving pulp business, please visit www.sappi.com .

SAB Biotherapeutics to Present Novel Human IgG Platform with Positive Data and Breakthrough Therapy and Fast-Track Designations for Influenza Treatment at BIO 2023 International Convention

Retrieved on: 
Tuesday, May 30, 2023

Dr. Sullivan will present positive clinical data supporting the use of SAB-176 as an effective treatment option for influenza, along with insights into the recent Breakthrough Therapy and Fast Track Designations granted by the U.S. Food and Drug Administration (FDA).

Key Points: 
  • Dr. Sullivan will present positive clinical data supporting the use of SAB-176 as an effective treatment option for influenza, along with insights into the recent Breakthrough Therapy and Fast Track Designations granted by the U.S. Food and Drug Administration (FDA).
  • “We look forward to presenting our platform’s latest advancements and research progress at BIO 2023,” Dr. Sullivan said.
  • “SAB Biotherapeutics is on a transformative journey, leveraging our novel immunotherapy platform to develop innovative therapeutic solutions like SAB-176, which holds tremendous promise in the treatment of influenza.
  • To learn more about partnering opportunities and SAB’s presence at BIO 2023, please contact Sheila Carlson at [email protected] .

SAB Biotherapeutics Presents Virtual 2023 R&D Day Portfolio Update: Breakthrough Immunotherapy Innovations

Retrieved on: 
Friday, May 19, 2023

SIOUX FALLS, S.D., May 19, 2023 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (NASDAQ: SABS ), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully-human immunoglobulins (hIgG), also known as fully-human polyclonal antibodies, without the need for human donors, announced today that it will be hosting its Virtual 2023 Annual R&D Day on Wednesday, June 14, 2023, at 1:30 P.M. CT.

Key Points: 
  • SIOUX FALLS, S.D., May 19, 2023 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (NASDAQ: SABS ), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully-human immunoglobulins (hIgG), also known as fully-human polyclonal antibodies, without the need for human donors, announced today that it will be hosting its Virtual 2023 Annual R&D Day on Wednesday, June 14, 2023, at 1:30 P.M. CT.
    During the event, SAB will provide a company overview of our novel immunotherapy platform DiversitAb™ along with a portfolio progress update including recent Breakthrough Therapy and Fast Track designations for SAB-176 anti-Influenza therapeutic and prophylactic biologics candidate.
  • In addition, SAB Executives and special guest KOL speaker, Dr. Michael Haller, will present important data validating SAB-142, a Type 1 diabetes therapeutic candidate.
  • Persons attending will learn about these important advancements in a powerful new class of biologics developed by SAB’s DiversitAb™ platform that produces targeted, high-potency, fully-human immunoglobulin (hIgG) antibodies without the need for human donors.
  • Register here to attend SAB 2023 Virtual R&D Day: SAB 2023 Annual R&D Day Registration Link
    A replay of the webcast will be made available on the SAB website following the event.

SAB Biotherapeutics Provides Company Update for Q1 2023 Financial Results

Retrieved on: 
Tuesday, May 16, 2023

SIOUX FALLS, S.D., May 16, 2023 (GLOBE NEWSWIRE) -- SAB Biotherapeutics ( Nasdaq: SABS ), (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully-human immunoglobulins (hIgG), also known as fully-human polyclonal antibodies, without the need for human donors, yesterday reported financial results for the first quarter ended March 31, 2023, and provided a company update.

Key Points: 
  • SIOUX FALLS, S.D., May 16, 2023 (GLOBE NEWSWIRE) -- SAB Biotherapeutics ( Nasdaq: SABS ), (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully-human immunoglobulins (hIgG), also known as fully-human polyclonal antibodies, without the need for human donors, yesterday reported financial results for the first quarter ended March 31, 2023, and provided a company update.
  • "Our first quarter 2023 results demonstrate that we continue to execute on our strategy to develop and deliver powerful immunotherapeutic treatments to patients with significant unmet needs.
  • We remain committed to advancing our programs and delivering much-needed therapies to patients worldwide,” said Eddie J. Sullivan, Ph.D., Co-Founder, President, and Chief Executive Officer of SAB Biotherapeutics.
  • The decrease was primarily due to discretionary cost reduction measures and increased efficiencies as the company continues to mature as a publicly traded company.

Meet Worldly - The Impact Intelligence Platform Used By 40,000+ of the Planet's Most Sustainability-Minded Brands and Manufacturers

Retrieved on: 
Tuesday, May 16, 2023

SAN FRANCISCO, May 16, 2023 /PRNewswire/ -- Most businesses want to do right by their customers and the planet, which is why today we're unveiling Worldly, the planet's most comprehensive Impact Intelligence platform. 

Key Points: 
  • "We believe the fashion, apparel and footwear industries are under tremendous pressure to transform how they do business," Worldly CEO Jason Kibbey said.
  • And forward-thinking governments and agencies are developing legislative frameworks to decarbonize manufacturing supply chains and protect workers.
  • The need for a sustainability intelligence platform like Worldly has never been greater.
  • Join us June 1 to learn more about Worldly, its factory data capability and SGS partnership.

Meet Worldly - The Impact Intelligence Platform Used By 40,000+ of the Planet's Most Sustainability-Minded Brands and Manufacturers

Retrieved on: 
Tuesday, May 16, 2023

SAN FRANCISCO, May 16, 2023 /PRNewswire/ -- Most businesses want to do right by their customers and the planet, which is why today we're unveiling Worldly, the planet's most comprehensive Impact Intelligence platform. 

Key Points: 
  • "We believe the fashion, apparel and footwear industries are under tremendous pressure to transform how they do business," Worldly CEO Jason Kibbey said.
  • And forward-thinking governments and agencies are developing legislative frameworks to decarbonize manufacturing supply chains and protect workers.
  • The need for a sustainability intelligence platform like Worldly has never been greater.
  • Join us June 1 to learn more about Worldly, its factory data capability and SGS partnership.